Candida Glabrata

Common Name(s)

Candida Glabrata

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Candida Glabrata" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Candida Glabrata" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Candida Glabrata" returned 214 free, full-text research articles on human participants. First 3 results:

Urinary Tract Infection with Candida glabrata in a Patient with Spinal Cord Injury.
 

Author(s): Monireh Rahimkhani, Mostafa Saberian, Alireza Mordadi, Sajad Varmazyar, Ali Tavakoli

Journal: Acta Med Iran. 2015 Aug;53(8):516-7.

 

Candida glabrata was thought to be a primarily non-pathogenic organism. However, with the ever-increasing population of immunocompromised individuals, it is considered to be an opportunistic pathogen. Patients with spinal cord injuries often using a long-term urinary catheter and ...

Last Updated: 7 Nov 2015

Go To URL
Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
 

Author(s): Laura Bedin Denardi, Débora Alves Nunes Mario, Érico Silva Loreto, Janio Morais Santurio, Sydney Hartz Alves

Journal:

 

In vitro interaction between tacrolimus (FK506) and four azoles (fluconazole, ketoconazole, itraconazole and voriconazole) against thirty clinical isolates of both fluconazole susceptible and -resistant Candida glabrata were evaluated by the checkerboard microdilution method. Synergistic, ...

Last Updated: 29 Jul 2015

Go To URL
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.
 

Author(s): Nicholas D Beyda, Guangling Liao, Bradley T Endres, Russell E Lewis, Kevin W Garey

Journal: Antimicrob. Agents Chemother.. 2015 Sep;59(9):5405-12.

 

The direct or indirect interactions that antifungals have with the host immune response may play a significant role in defining their activity in vivo. However, the impact that acquired antifungal resistance has on the immunopharmacologic activity of antifungals is not well described. ...

Last Updated: 15 Aug 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Candida Glabrata" returned 7 free, full-text review articles on human participants. First 3 results:

Candida glabrata: new tools and technologies-expanding the toolkit.
 

Author(s): Hsueh-lui Ho, Ken Haynes

Journal: FEMS Yeast Res.. 2015 Sep;15(6):.

 

In recent years, there has been a noticeable rise in fungal infections related to non-albicans Candida species, including Candida glabrata which has both intrinsic resistance to and commonly acquired resistance to azole antifungals. Phylogenetically, C. glabrata is more closely related ...

Last Updated: 18 Aug 2015

Go To URL
Tipping the balance both ways: drug resistance and virulence in Candida glabrata.
 

Author(s): Luis A Vale-Silva, Dominique Sanglard

Journal: FEMS Yeast Res.. 2015 Jun;15(4):fov025.

 

Among existing fungal pathogens, Candida glabrata is outstanding in its capacity to rapidly develop resistance to currently used antifungal agents. Resistance to the class of azoles, which are still widely used agents, varies in proportion (from 5 to 20%) depending on geographical ...

Last Updated: 11 Jun 2015

Go To URL
Candida glabrata: a deadly companion?
 

Author(s): Monique Bolotin-Fukuhara, Cécile Fairhead

Journal: Yeast. 2014 Aug;31(8):279-88.

 

The yeast Candida glabrata has become a major fungal opportunistic pathogen of humans since the 1980s. Contrary to what its name suggests, it is much closer, phylogenetically, to the model yeast Saccharomyces cerevisiae than to the most prevalent human fungal pathogen, Candida albicans. ...

Last Updated: 18 Aug 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.